Lahore: In a recent development at Ferozsons Laboratories Limited, an independent director has executed a small-scale share transaction, as disclosed under the Pakistan Stock Exchange's Regulation 5.6.4. According to the official notice dated June 19, 2026, Suleman Ghani, who serves as an independent director at the company, has purchased a single share in the ready market.

The transaction was conducted at a rate of 410.00 per share. As a result of this purchase, the cumulative number of shares held by Mr. Ghani stands at one, representing a cumulative percentage of 0.00%. The nature of this transaction has been categorized as a 'buy' within the designated market category.

According to information available from the Pakistan Stock Exchange (PSX), such disclosures are essential for maintaining transparency and informing shareholders and potential investors about the activities of key company personnel. This particular transaction, however, reflects no change in percentage terms within the company's shareholding structure, given its negligible size.

This disclosure is part of the company's compliance with regulatory requirements, ensuring that the public is apprised of any changes in the shareholding patterns of its directors and substantial shareholders.